Skip to main content

Advertisement

SpringerLink
Log in

Jail management of arrestees/inmates enrolled in community methadone maintenance programs

  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

Anecdotal evidence suggests that many jails fail to adequately detoxify arrestees/inmates who are enrolled in methadone programs, but there are few empirical data. The objective of this study was to assess how jails manage arrestees/inmates enrolled in methadone programs. A national survey of 500 jails in the United States was conducted. Surveys were mailed to the 200 largest jails in the country in addition to a random sample of 300 of the remaining jails (10% sample). Jails were specifically asked about management of opiate dependency among arrestees/inmates enrolled in methadone programs. Weighted logistic regression analyses were conducted to assess predictors of continuing methadone during incarceration and use of recommended detoxification protocols. Among the 245 (49%) jails that responded, only 1 in 4 (27%) reported they contacted the methadone programs regarding dose, and only 1 in 8 (12%) continued methadone during the incarceration. Very few (2%) jails used methadone or other opiates for detoxification. Most used clonidine. However, half (48%) of jails failed to use clonidine, methadone, or other opiates to detoxify inmates from methadone. Weighted logistic regression models showed that moderately large jails and those located in the South and Midwest were significantly more likely to continue methadone. Very large jails, those with an estimated prevalence of opiate dependence of 6%–10% among arrestees/inmates, and those located in the Northeast were significantly more likely to use recommended detoxification protocols. Very few jails provided continuous treatment to arrested persons on methadone, and half failed to detoxify arrestees/ inmates using recommended protocols. These practices jeopardize the health and wellbeing of persons enrolled in methadone programs and underscore the need for uniform national policies within jails.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Young L. Improving quality and oversight of methadone treatment. SAMHSA News, 1999. Available at:http://www.samhsa.gov/press/99/990722fs.htm.Accessed August 10, 2001.

  2. Appel PW, Joseph H, Kott A, Nottingham W, Tasiny E, Habel E. Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State. Mt Sinai Med. 2001;68:55–61.

    CAS  Google Scholar 

  3. Dillman DA. Mail and Telephone Surveys: The Total Design Method. New York, NY: John Wiley and Sons; 1978.

    Google Scholar 

  4. Stephan JJ. Census of Jails, 1999. Washington, DC: US Dept of Justice; August, 2001.

    Google Scholar 

  5. National Institute of Justice. Annual Report 2000: Arrestee Drug Abuse Monitoring. Washington, DC: US Dept of Justice; 2003.

    Google Scholar 

  6. O’Connor PG, Kosten TR. Management of opioid intoxication and withdrawal. In: Graham AW, Schulz TK, eds. Principles of Addiction Medicine. Chevy Chase, MD: American Society of Addiction Medicine; 2000:457–464.

    Google Scholar 

  7. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91:1842–1846.

    CAS  PubMed  Google Scholar 

  8. Tomasino V, Swanson AJ, Nolan J, Shuman HI. The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates. Mt Sinai J Med. 2001;68:14–20.

    CAS  PubMed  Google Scholar 

  9. Bach PB, Lantos J. Methadone dosing, heroin affordability, and the severity of addiction. Am J Public Health. 1999;89:662–665.

    CAS  PubMed  Google Scholar 

  10. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am J Psychiatry. 1995;152(suppl):1–59.

    Google Scholar 

  11. Federal Bureau of Prisons. Clinical Practice Guidelines: Detoxification of Chemically Dependent Persons. Washington, DC, National Institute of Corrections; 2000:1–44.

    Google Scholar 

  12. O’Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ. Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med. 1997;127:526–530.

    CAS  PubMed  Google Scholar 

  13. San L, Cami J, Peri JM, Mata R, Porta M. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial. Br J Addict. 1990;85:141–147.

    Article  CAS  PubMed  Google Scholar 

  14. Armenian SH, Chutuape MA, Stitzer ML. Predictors of discharges against medical advice from a short-term hospital detoxification unit. Drug Alcohol Depend. 1999;56:1–8.

    Article  CAS  PubMed  Google Scholar 

  15. Ghodse H, Myles J, Smith SE. Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction. Br J Psychiatry. 1994;165:370–374.

    Article  CAS  PubMed  Google Scholar 

  16. Kosten TR, Rounsaville BJ, Kleber HD. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts Am J Drug Alcohol Abuse. 1985;11:1–10.

    CAS  PubMed  Google Scholar 

  17. Gowing LR, Farrell M, Ali RL, White JM. Alpha2-adrenergic agonists in opioid with-drawal. Addiction. 2002;97:49–58.

    Article  PubMed  Google Scholar 

  18. McCann MJ, Miotto K, Rawson RA, Huber A, Shoptaw S, Ling W. Outpatient non-opioid detoxification for opioid withdrawal. Who is likely to benefit? Am J Addict. 1997;6:218–223.

    Article  CAS  PubMed  Google Scholar 

  19. Dole VP. Detoxification of sick addicts in prison. JAMA. 1972;220:366–369.

    Article  CAS  PubMed  Google Scholar 

  20. Magura S, Rosenblum A, Joseph H. Evaluation of in-jail methadone maintenance: preliminary results. NIDA Res Monogr. 1992;118:192–210.

    CAS  PubMed  Google Scholar 

  21. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2002; CD002207.

  22. Gowing L, Ali R, White J. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev. 2002;CD002025.

  23. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000; 284:1689–1695.

    Article  CAS  PubMed  Google Scholar 

  24. Fiscella K, Pless N, Meldrum S, Fiscella P. Benign neglect or neglected abuse: drug and alcohol withdrawal in US jails. J Law Med Ethics. 2004;32:129–136.

    PubMed  Google Scholar 

  25. Curitis HP. Medical examiner feels pressure; Dr. William Anderson said his ruling in a jail death invited repercussions from orange. Orlando Sentinel. July 4, 2002: A1

  26. Substance Abuse and Mental Health Services Administration. Substance Abuse Treatment In Adult and Juvenile Correctional Facilities: Findings from the Uniform Facilities Data Set 1997 Survey of Correctional Facilities. Rockville, MD:Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2000. Available at: http://www.samhsa.gov/oas/UFDS/CorrectionalFacilities97/index.htm. Accessed July 20, 2001.

    Google Scholar 

  27. Wilson DJ. Drug Use, Testing, and Treatment in Jails. Washington, DC: US Government Printing Office, Bureau of Justice Statistics; 2000. NCJ179999,. Available at: http://www.ojp.usdoj.gov;80/bjs/pub/pdf/duttj.pdf.Accessed August 21, 2002.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York

    Kevin Fiscella,  Judith Engerman &  Sean Meldrum

  2. Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York

    Kevin Fiscella

  3. University of Rochester School of Medicine and Dentistry, Rochester, New York

    Andrew Moore

Authors
  1. Kevin Fiscella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Judith Engerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sean Meldrum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin Fiscella.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fiscella, K., Moore, A., Engerman, J. et al. Jail management of arrestees/inmates enrolled in community methadone maintenance programs. J Urban Health 81, 645–654 (2004). https://doi.org/10.1093/jurban/jth147

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1093/jurban/jth147

Keywords

Search

Navigation